Related Experiment Video
Updated: Jun 21, 2026
11:36
A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Ghrelin and its therapeutic potential for cachectic patients
Jun-ichi Ashitani1, Nobuhiro Matsumoto, Masamitsu Nakazato
1Division of Neurology, Respirology, Endocrinology and Metabolism, The Third Department of Internal Medicine, Miyazaki University School of Medicine, Kihara 5200, Miyazaki 889-1692, Japan. jashi2@fc.miyazaki-u.ac.jp
Peptides
|July 15, 2009
Summary
Ghrelin, a stomach-derived peptide, signals starvation to the brain, increasing appetite. It shows promise in treating cachexia by boosting lean mass and improving quality of life.
Area of Science:
- Endocrinology
- Molecular Biology
- Physiology
Background:
- Ghrelin is a recently discovered peptide hormone produced in the stomach.
- It plays a crucial role in regulating appetite and energy balance.
- Ghrelin is unique in signaling starvation from the periphery to the central nervous system.
Purpose of the Study:
- To investigate the role of ghrelin in the pathophysiology of cachectic diseases.
- To explore the potential of ghrelin as a therapeutic agent for cachexia.
Main Methods:
- Molecular analyses of appetite regulation mechanisms.
- Clinical trials in cachectic patients.
- Basic research using animal models.
Main Results:
- Ghrelin administration increased lean body mass and activity in cachectic patients.
- Ghrelin demonstrated orexigenic, anabolic, and anti-inflammatory effects.
- Ghrelin counteracts the cachectic paradigm by mitigating appetite loss and inflammation.
Conclusions:
- Ghrelin has a significant role in the pathophysiology of cachectic diseases.
- Ghrelin administration holds potential for improving the quality of life in cachectic patients.
- Ghrelin represents a promising therapeutic target for cachexia and related conditions.
Related Concept Videos
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:16Gastric Emptying
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
01:40Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...